Concepedia

Plasma tau protein and Aβ42 level as markers of cognitive impairment in patients with Parkinson’s disease

Justyna Chojdak-Łukasiewicz, Małgorzata Małodobra-Mazur, Anna Zimny, Leszek Noga, Bogusław Paradowski

Advances in Clinical and Experimental Medicine · 2020 · 24 citations · 11 references

DOIFull text

Open access

Abstract

Serum levels of Aβ42 and tau protein in PD may be a useful marker for the assessment of cognitive impairments. The role of L-DOPA in the process of dementia in PD remains unclear.

References

11

Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study

Oscar L. López, Lewis H. Kuller, P. D. Mehta et al. · Neurology · 2008 · 160 citations · Full text

Chronic kidney disease is associated with dementia independent of cerebral small-vessel disease

Kaori Miwa, Makiko Tanaka, Shuhei Okazaki et al. · Neurology · 2014 · 113 citations

Tau protein in cerebrospinal fluid (CSF): a blood–CSF barrier related evaluation in patients with various neurological diseases

Sigurd D. Süßmuth, Hansotto Reiber, Hayrettin Tumani · Neuroscience Letters · 2001 · 102 citations

, , +11

Expression of high molecular weight tau in the central and peripheral nervous systems

Irene S. Georgieff, Ronald K.H. Liem, Dominique Couchie et al. · Journal of Cell Science · 1993 · 93 citations

Association Between Serum Amyloid-Beta and Renal Functions: Implications for Roles of Kidney in Amyloid-Beta Clearance

Yu-Hui Liu, Yang Xiang, Ye‐Ran Wang et al. · Molecular Neurobiology · 2014 · 80 citations

, , +10